Compounds > 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide
Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and ro 16-0154

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with ro 16-0154 in 1 studies

Compound Research Comparison

Studies
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Trials
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Recent Studies (post-2010)
(3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide)		Studies
(ro 16-0154)		Trials
(ro 16-0154)		Recent Studies (post-2010) (ro 16-0154)
33040332493259

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagspiel, KD; Hermes, M; Kujat, C; Neidl, KF; Voges, M1

Reviews

1 review(s) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and ro 16-0154

ArticleYear
[Single photon emission tomography (SPECT). Cerebral function diagnosis for the clinical routine. Indications and radiotracers].
    Der Radiologe, 1993, Volume: 33, Issue:11

    Topics: Benzamides; Brain Diseases; Flumazenil; Humans; Iodine Radioisotopes; Organotechnetium Compounds; Oximes; Pyrrolidines; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon

1993